Cardiol Therapeutics Inc. Class A Common Shares (CRDL)

About CRDL

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Website

www.cardiolrx.com/

Fundamentals

Market cap

$156.77M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.39

Dividend yield

—

Beta

2.41

Avg. volume

—

Cardiol Therapeutics Inc. Class A Common Shares Competitors

Chosen by industry and closest market cap.

• CRDL

  Cardiol Therapeutics Inc. Class A Common Shares

  $1.94

  ▼ 6.07%
  Market cap $156.77MP/E —
  $1.23$3.15
• TNYA

  Tenaya Therapeutics Inc. Common Stock

  $0.691

  ▼ 0.58%
  Market cap $157.50MP/E —
  $0.532$2.35
• HUMA

  Humacyte Inc. Common Stock

  $0.6538

  ▼ 5.66%
  Market cap $157.54MP/E —
  $0.5261$2.55
• CRBU

  Caribou Biosciences Inc. Common Stock

  $1.62

  ▼ 2.41%
  Market cap $162.66MP/E —
  $1.38$3.54
• MOLN

  Molecular Partners AG American Depositary Shares

  $4.5

  ▼ 3.27%
  Market cap $163.47MP/E —
  $2.66$3.96
• LENZ

  LENZ Therapeutics Inc. Common Stock

  $5.12

  ▲ 6.34%
  Market cap $163.67MP/E —
  $4.54$50.4
• ARMP

  Armata Pharmaceuticals Inc. Common Stock

  $5.24

  ▼ 3.50%
  Market cap $172.54MP/E —
  $2.4$16.34

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Wednesday's Intraday Session
  Benzinga · 8/26/2026
• Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?
  Yahoo · 8/24/2026
• Canaccord Genuity Maintains Buy on Cardiol Therapeutics, Raises Price Target to $10
  Benzinga · 8/17/2026
• Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial
  Yahoo · 8/12/2026
• Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
  Yahoo · 8/5/2026

Institutional Ownership

March 31, 2026

Total shares held

27.84M

Total value held

$37.54M

Institutional holders

45